PM01183 . Phase I Study of Lurbinectedin in Combination With Paclitaxel, With or Without Bevacizumab, in Selected Advanced Solid Tumors . ¡¡ This study has been completed !! .

Status : Completed .

Sponsor : PharmaMar .

Information provided by (Responsible Party) : PharmaMar .



Condition :

* Breast Cancer

* Ovarian Cancer

* Gynecological Cancer

* Head and Neck Carcinoma

* Non-small Cell Lung Cancer

* Small Cell Lung Cancer

* Non-squamous Cell Lung Cancer .

*************************************

Enrollment : 69

Study Start Date : September 2013

Study Completion Date : July 2016

Primary Completion Date : July 2016 (Final data collection date for primary outcome measure) .

*************************************

Health Authority:

* United States: Food and Drug Administration

* Spain: Agencia Española de Medicamentos y Productos Sanitarios

* Switzerland: Swissmedic .

...